Stock 0TDF ROCHE HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

News Roche Holding AG London S.E.

Equities

0TDF

US7711951043

Market Closed - London S.E.
Other stock markets
 07:01:49 12/06/2024 pm IST 		5-day change 1st Jan Change
34.01 USD +7.19% Intraday chart for Roche Holding AG -3.19% -5.26%
25/06 Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval MT
25/06 Roche: approval of Ocrevus SC in Europe CF

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval
MT
Roche: approval of Ocrevus SC in Europe
CF
Roche Wins EU Nod for Subcutaneous Formula of Multiple Sclerosis Drug Ocrevus
MT
Roche's Multiple Sclerosis Injection Gets EU Approval
DJ
Halozyme Therapeutics, Inc. Announces Roche's OCREVUS SC with ENHANZE Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
CI
Roche Announces the European Commission Grants Marketing Authorisation for OCREVUS (Ocrelizumab) Subcutaneous for the Treatment of Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis
CI
Swiss Market Index in Green as Investors Keep Eye on European Politics
MT
Global markets live: Novo Nordisk, Apple, UPS, Eli Lilly, Qualcomm...
Our Logo
Foreign banks target Switzerland after UBS takeover of Credit Suisse
RE
ROCHE HOLDINGS AG : Barclays reiterates its Neutral rating
ZD
Roche: two new units for cobas pro
CF
Roche: marketing authorization application validated for Elevidys in Europe
CF
European Medicines Agency Begins Review of Roche's Gene Therapy for Duchenne Muscular Dystrophy
MT
US FDA approves Roche's drug for a chronic blood disorder
RE
Nykredit Bank Initiates Coverage on Roche With Buy Recommendation
MT
Nykredit Bank Starts Roche Coverage at Buy
MT
Sarepta Therapeutics Gets Expanded Label FDA Approval for Duchenne Muscular Dystrophy; Shares Soar Premarket
MT
Sarepta Therapeutics Gets Expanded US FDA Approval for Treatment of Duchenne Muscular Dystrophy; Shares Soar After Hours
MT
US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump
RE
Sarepta Shares Soar 37% Following Expanded Approval for Elevidys
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ROG Stock
  4. 0TDF Stock
  5. News Roche Holding AG